» Articles » PMID: 32351703

P53 Suppresses SENP3 Phosphorylation to Mediate G2 Checkpoint

Overview
Journal Cell Discov
Date 2020 May 1
PMID 32351703
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In response to DNA damage, p53-mediated signaling is regulated by protein phosphorylation and ubiquitination to precisely control G2 checkpoint. Here we demonstrated that protein SUMOylation also engaged in regulation of p53-mediated G2 checkpoint. We found that G2 DNA damage suppressed SENP3 phosphorylation at G2/M phases in p53-dependent manner. We further found that the suppression of SENP3 phosphorylation was crucial for efficient DNA damage/p53-induced G2 checkpoint and G2 arrest. Mechanistically, we identified Cdh1, a subunit of APC/C complex, was a SUMOylated protein at G2/M phase. SENP3 could de-SUMOylate Cdh1. DNA damage/p53-induced suppression of SENP3 phosphorylation activated SENP3 de-SUMOylation of Cdh. De-SUMOylation promoted Cdh1 de-phosphorylation by phosphatase Cdc14B, and then activated APC/C E3 ligase activity to ubiquitate and degrade Polo-like kinase 1 (Plk1) in process of G2 checkpoint. These data reveal that p53-mediated inhibition of SENP3 phosphorylation regulates the activation of Cdc14b-APC/C-Plk1 axis to control DNA damage-induced G2 checkpoint.

Citing Articles

GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner.

Rivas V, Gonzalez-Munoz T, Albitre A, Lafarga V, Delgado-Arevalo C, Mayor Jr F Cell Death Discov. 2024; 10(1):385.

PMID: 39198399 PMC: 11358448. DOI: 10.1038/s41420-024-02143-8.


AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury.

Zhu M, He J, Xu Y, Zuo Y, Zhou W, Yue Z Mol Ther. 2023; 31(10):3052-3066.

PMID: 37608549 PMC: 10556228. DOI: 10.1016/j.ymthe.2023.08.014.


A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer.

Li S, Yan L, Wei X, Jia Z, Yang J, Ning X Front Pharmacol. 2023; 14:1038457.

PMID: 37201027 PMC: 10185777. DOI: 10.3389/fphar.2023.1038457.


Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

Jin S, He X, Ma L, Zhuang Z, Wang Y, Lin M Nat Commun. 2022; 13(1):5204.

PMID: 36057605 PMC: 9440653. DOI: 10.1038/s41467-022-32957-y.


Mitotic SENP3 activation couples with cGAS signaling in tumor cells to stimulate anti-tumor immunity.

Hu G, Chen Y, Yang X, Wang Y, He J, Wang T Cell Death Dis. 2022; 13(7):640.

PMID: 35869062 PMC: 9307842. DOI: 10.1038/s41419-022-05063-6.


References
1.
Geiss-Friedlander R, Melchior F . Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007; 8(12):947-56. DOI: 10.1038/nrm2293. View

2.
Wan J, Subramonian D, Zhang X . SUMOylation in control of accurate chromosome segregation during mitosis. Curr Protein Pept Sci. 2012; 13(5):467-81. PMC: 3474960. DOI: 10.2174/138920312802430563. View

3.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

4.
Cardozo T, Pagano M . The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol. 2004; 5(9):739-51. DOI: 10.1038/nrm1471. View

5.
Eifler K, Cuijpers S, Willemstein E, Raaijmakers J, El Atmioui D, Ovaa H . SUMO targets the APC/C to regulate transition from metaphase to anaphase. Nat Commun. 2018; 9(1):1119. PMC: 5856775. DOI: 10.1038/s41467-018-03486-4. View